These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36556238)

  • 1. Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma.
    Li G; Chen W; Gong Y; Wei T; Gong R; Zhu J; Li Z; Lei J
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
    Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
    Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas.
    Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J
    Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
    Dai D; Tan Y; Guo L; Tang A; Zhao Y
    Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
    Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
    Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma.
    Gierlikowski W; Broniarek K; Cheda Ł; Rogulski Z; Kotlarek-Łysakowska M
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
    Wang Z; Lv J; Zou X; Huang Z; Zhang H; Liu Q; Jiang L; Zhou X; Zhu W
    Gene; 2019 Apr; 693():37-45. PubMed ID: 30684524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
    Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
    Front Genet; 2020; 11():449. PubMed ID: 32508877
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Children, Adolescents, and Young Adults.
    Tian T; Huang S; Dai H; Qi M; Liu B; Huang R
    J Clin Endocrinol Metab; 2023 Jan; 108(2):306-314. PubMed ID: 36226635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma.
    Wen Q; Wang Y; Li X; Jin X; Wang G
    J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
    Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
    Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
    Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
    Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
    Tang Y; Meng X; Yu X; Shang H; Chen S; Liao L; Dong J
    J Endocrinol Invest; 2020 Apr; 43(4):439-450. PubMed ID: 31612419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.
    Capriglione F; Verrienti A; Celano M; Maggisano V; Sponziello M; Pecce V; Gagliardi A; Giacomelli L; Aceti V; Durante C; Bulotta S; Russo D
    Endocrine; 2022 Jan; 75(1):185-193. PubMed ID: 34378123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma.
    Wang J; Xu Q; Xuan Z; Mao Y; Tang X; Yang K; Song F; Zhu X
    Oncologist; 2024 Sep; 29(9):e1120-e1131. PubMed ID: 38760956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
    Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
    Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma.
    Zang CS; Huang HT; Qiu J; Sun J; Ge RF; Jiang LW
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4890-4900. PubMed ID: 32432752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.